BiopsyBreastBiopsy, NeedleCarcinoma, Ductal, BreastBreast DiseasesBreast FeedingBreast Neoplasms, MaleMammographyReceptors, EstrogenFibrocystic Breast DiseaseCell Line, TumorReceptor, erbB-2Breast ImplantsReceptors, ProgesteroneBreast Self-ExaminationTamoxifenImage-Guided BiopsyPrognosisCarcinoma, Intraductal, NoninfiltratingBiopsy, Large-Core NeedleTumor Markers, BiologicalBiopsy, Fine-NeedleUltrasonography, MammaryImmunohistochemistryGene Expression Regulation, NeoplasticMastectomyCarcinoma, LobularNeoplasm InvasivenessSentinel Lymph Node BiopsyNeoplasm StagingLymphatic MetastasisNeoplasm MetastasisCase-Control StudiesRisk FactorsSensitivity and SpecificityAntineoplastic Agents, HormonalGenes, BRCA1Retrospective StudiesCarcinomaPostmenopauseMastectomy, SegmentalBreast CystTumor Cells, CulturedFibroadenomaAxillaNeoplasm ProteinsAntineoplastic AgentsMammaplastyMilk, HumanNipplesChemotherapy, AdjuvantFollow-Up StudiesTime FactorsMammary Glands, HumanTreatment OutcomeEstrogen Receptor alphaCarcinoma in SituEstrogensPremenopauseMCF-7 CellsProspective StudiesMammary Neoplasms, ExperimentalPredictive Value of TestsNeoplasm Recurrence, LocalMenopauseCell ProliferationRNA, MessengerBreast ImplantationCarcinoma, DuctalGene Expression ProfilingBRCA2 ProteinReproducibility of ResultsBRCA1 ProteinGenes, BRCA2Neoplasms, Hormone-DependentCohort StudiesReverse Transcriptase Polymerase Chain ReactionDisease-Free SurvivalGenes, erbB-2Survival AnalysisLymph NodesTriple Negative Breast NeoplasmsIncidenceInflammatory Breast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsGenetic Predisposition to DiseaseEstrogen AntagonistsAromatase InhibitorsDisease ProgressionAge FactorsMice, NudeVacuumDrug Resistance, NeoplasmRisk AssessmentFalse Negative ReactionsRiskImmunoenzyme TechniquesPolymerase Chain ReactionMass ScreeningEstradiol